1-((4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)pneumocandin B0, diacetate (salt)

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

33 Suppliers, 12 USDMF, 1 JDMF, 5 EU WC, 6 KDMF, 7 NDC API, 26 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

80 Dossiers, 16 FDA Orange Book, 10 Europe, 6 Canada, 16 South Africa, 32 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INTRAVENOUS - 50MG/VIAL, POWDER;INTRAVENOUS - 70MG/VIAL

RELATED EXCIPIENT COMPANIES

Suppliers, 12 SPI Pharma, 3 Pfanstiehl, 3 DKSH, 3 Roquette, 3 Gangwal Chemicals, 2 Kerry, 2 Microlex e.U, 2 Gangwal Healthcare, 2 Actylis, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Rochem International Inc, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Ingredion Pharma Solutions, 1 BASF

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 12 Taste Masking, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 4 Thickeners and Stabilizers, 4 Parenteral, 4 Co-Processed Excipients, 3 Coating Systems & Additives, 3 Disintegrants & Superdisintegrants, 3 Granulation, 1 API Stability Enhancers, 1 Topical

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 8 Finished Drug Prices

MARKET PLACE

16 APIs, 5 DOSSIERS // FDF

PATENTS

2 US Patents, 4 Health Canada Patents

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 15 News

Annual Sales of 1-((4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)pneumocandin B0, diacetate (salt) reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

1-((4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)pneumocandin B0, diacetate (salt)

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

33 Suppliers

12 USDMF

1 JDMF

5 EU WC

6 KDMF

7 NDC API

26 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

80 Dossiers

16 FDA Orange Book

10 Europe

6 Canada

16 South Africa

32 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INTRAVENOUS - 50MG/VIAL

POWDER;INTRAVENOUS - 70MG/VIAL

RELATED EXCIPIENT COMPANIES

Suppliers

12 SPI Pharma

3 Pfanstiehl

3 DKSH

3 Roquette

3 Gangwal Chemicals

2 Kerry

2 Microlex e.U

2 Gangwal Healthcare

2 Actylis

1 Shijiazhuang Huaxu Pharmaceutical

1 Rochem International Inc

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Sigachi Industries

1 Ingredion Pharma Solutions

1 BASF

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

12 Taste Masking

10 Direct Compression

10 Chewable & Orodispersible Aids

4 Thickeners and Stabilizers

4 Parenteral

4 Co-Processed Excipients

3 Coating Systems & Additives

3 Disintegrants & Superdisintegrants

3 Granulation

1 API Stability Enhancers

1 Topical

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

8 Finished Drug Prices

MARKET PLACE

16 APIs

5 DOSSIERS // FDF

PATENTS

2 US Patents

4 Health Canada Patents

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow

15 News

1-((4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine)-5-((3R)-3-hydroxy-L-ornithine)pneumocandin B0, Diacetate (salt)

Merck & Co.

Caspofungin Acetate

Cancidas

Anti-Fungal

USD